Skip to main content

Garrett T. Galvin


[email protected]



Garrett focuses his practice on corporate law, transactional work, including private sales and acquisitions, and general corporate matters including reorganizations, corporate governance issues and commercial contracts. He represents private equity clients as well as clients across the energy and sustainability, life sciences and technology industries.

While attending law school, Garrett served as a legal intern with a biopharmaceutical company focused on developing cancer treatments. In that role, he assisted in the implementation of a globally compliant privacy program and with the assessment and reporting of an international data privacy incident. He was also a legal intern at a pharmaceutical company that is developing medicine to control the expression of genes. In that role, he negotiated and drafted commercial contracts and implemented a contract management system.

Prior to attending law school, Garrett worked as a business analyst in supply chain operations with a California-based global information technology company, a business analyst with a Canadian multinational financial services company, and a document control officer in the corporate financing division of a Canadian multinational bank.


  • Represented Liberty Power, an independent retail electricity supplier, in its negotiation of a multi-year supply agreement with Boston Energy Trading and Marketing LLC, restructuring of its existing capital structure, and entry into new financing arrangements.
  • Represented a national distributed solar developer in its acquisitions of solar energy Project Companies in New York, Massachusetts, New Hampshire, Maryland, Pennsylvania and Texas.
  • Represented cloud computing company Rocket Innovations, Inc. in the sale of Rocketbook, the leading smart reusable notebook brand in the United States, to BIC, a global manufacturing company of disposable consumer products such as stationery, lighters, and shavers.
  • Represented Capstone Partners, an investment banking and advisory firm serving middle market companies, in its sale to Huntington Bancshares Incorporated (Nasdaq: HBAN).
  • Represented Albireo Pharma, a biotechnology company focused on developing treatments for rare disease in its sale to French biotechnology firm Ipsen SA.
  • Represented Med-Pharmex, a manufacturer of generic veterinary drugs and portfolio company of private equity firm DW Healthcare Partners, in its sale to Dechra Pharmaceuticals, a British-owned developers and manufacturer of veterinary products.
  • Represented XL Fleet Corp., a developer and manufacturer of vehicle electrification solutions, in its de-SPAC merger with Pivotal Investment Corporation II, a special purpose acquisition company.
Read less


Stock Vesting in Startup Companies

March 15, 2022 | Article | By Alex Civetta, Garrett Galvin

Building a company from the ground up is a risky endeavor for founders. In exchange for the founders’ efforts and devotion to the success of the company, the founders take a significant equity stake in the company, with the expectation that the value of these shares will grow substantially as the company grows.
Read more

The Beauty and the Terror of Agile Software Development

March 24, 2021 | Advisory | By Alex Civetta, Garrett Galvin

This Mintz advisory reviews the challenges associated with agile software development contracts and provides best practices to avoid rising costs and legal disputes.
Read more
On January 19, 2021 the United States Court of Appeals for the District of Columbia Circuit (the “DC Circuit”) vacated the Affordable Clean Energy Rule (the “ACE Rule”), a policy instituted by the Environmental Protection Agency (the “EPA”) on June 19, 2019 that weakened emissions standards for power plants and empowered states to set their own energy standards.
Read more
In a slip opinion issued on November 19, 2020, the United States Court of International Trade (“USCIT”) permitted the imposition of tariffs on bifacial solar panels, a victory for the Trump administration’s years-long effort to limit imports of foreign-made solar technologies.
Read more
On September 17, 2020, the Federal Energy Regulatory Commission issued Order No. 2222 to allow for the greater participation of distributed energy resource aggregations in organized wholesale markets. The long-awaited rule is aimed at increasing competition in electric markets, enhancing grid flexibility and reliability, and leveling the playing field when it comes to organized capacity, energy, and ancillary services run by regional grid operators.
Read more
A petition filed in April by the New England Ratepayers Association (NERA) has requested that the Federal Energy Regulatory Commission (FERC) reassess its authority over retail solar sales, stating that the federal government, through FERC, not individual state legislatures and public utility commissions, has exclusive jurisdiction over wholesale energy sales and should end the practice of net metering.
Read more
Read less

News & Press

Press Release Thumbnail
WASHINGTON, DC – Mintz served as legal counsel to Invited, Inc. in its sale of certain assets related to its BigShots Golf business to Topgolf Callaway Brands Corp.
Press Release Thumbnail
BOSTON– Mintz represented Gradiant Corporation, a global end-to-end solutions provider of advanced water and wastewater treatment, in its Series D financing.
News Thumbnail
Mintz's role acting for biotechnology company Albireo Pharma in its sale to Ipsen was covered in The Deal. The article featured Mintz Members Megan Gates, and John Condon and Associate Garrett Galvin, who led for the firm.
Press Release Thumbnail
The deal will take public ProKidney, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease, and is expected to provide up to $825 million in gross cash proceeds.
Read less